Targeting Glycolysis as a New Approach to the Treatment of Epilepsy

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 05/17/2019

Pipeline Type

Dietary Supplements

Phase Of Development

Preclinical

Sponsors and Collaborators

Baylor College of Medicine, Epilepsy Research Foundation, NIH-NINDS (NS039941)

Mechanism of Action

Mechanism Description

fructose-1,6-bisphosphate to inhibit glycolysis (shifts metabolism of glusose from glycolytic pathway to pentose phosphate pathway)

Populations Tested In

N/A

Other Resources

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation - NTCG 2005

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
No presentations found. Published JNeuroscience,27(44):12007-12011, 2007

Location of Clinical Trials

Baylor College of Medicine

Clinical Trial link

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.